Atomy Eye-Lutein
Natural health product licensed in Canada
- Licence holder
- Atomy Canada Inc.
- NPN or DIN-HM
- 80078240
- Status
- Inactive licence
- Licence date
- 8 June 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 20 milligramme | Not calculated |
| Zinc Source : Oxyde de zinc | 5.42 milligramme | 5,420 µg |
| Vitamine A Source : Palmitate de vitamine A extrait de l'huile de foie de morue | 275 mg RAE | Not calculated |
| Borago officinalis Source : Borago officinalis - Graine | 51 milligramme | Not calculated |
Non-medicinal ingredients
Huile de tournesol, Fruit séché de goji, Acide hyaluronique, Carbonate de calcium, d-alpha tocophérol, Lécithine, Amidon de maïs modifié, Extrait du fruit de sureau, Poudre de bleuet, Extrait de fruit d'orange, Extrait de fruit d'airelle à feuilles ovées, Cire d'abeille, Dextrine, Maltodextrine, Extrait de fruits d'Aronia melanocarpa(cerise noire de Virginie), Citrate de trisodium dihydraté, Phosphate de sodium, dibasique, Glycérine, Huile de pépin de raisin, Extrait de fruit de Ribes Nigrum (Cassis), Extrait de baies de Vaccinium Uliginosum, Huile d'arachide, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 1 Capsule | minimum: 1 day ; maximum: 1 day |
Uses authorised in Canada
Antioxidant for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80078240
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.